United States · FDA National Drug Code directory

Carcinosin Miasm Drops 2142

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63083-2142_64ee9159-2ce5-4e0a-9db6-a0657a1f3691
Product NDC
63083-2142
Form
LIQUID
Composition / generic term
Carcinosin Miasm Drops
Labeler
Professional Complementary Health Formulas
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
19840815
Source listing expiry
20271231

Source-listed ingredients

  • GOLD TRICHLORIDE — 6 [hp_X]/59mL
  • COMFREY ROOT — 6 [hp_X]/59mL
  • HEKLA LAVA — 8 [hp_X]/59mL
  • LACTIC ACID, L- — 15 [hp_X]/59mL
  • ASTERIAS RUBENS — 30 [hp_X]/59mL
  • CROTALUS HORRIDUS HORRIDUS VENOM — 30 [hp_X]/59mL
  • THUJA OCCIDENTALIS LEAF — 30 [hp_X]/59mL
  • CLAVICEPS PURPUREA SCLEROTIUM — 60 [hp_X]/59mL
  • MELANDRIN — 100 [hp_X]/59mL
  • HUMAN BREAST TUMOR CELL — 100 [hp_X]/59mL
  • ARSENIC TRIOXIDE — 200 [hp_X]/59mL
  • LIQUID PETROLEUM — 200 [hp_X]/59mL
  • SULFUR — 200 [hp_X]/59mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 59 mL in 1 BOTTLE, DROPPER (63083-2142-2) · 63083-2142-2

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →